BioCentury
ARTICLE | Company News

Takeda acquiring TiGenix for €520M

January 5, 2018 9:11 PM UTC

Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) said Friday it will acquire TiGenix N.V. (Euronext:TIG; NASDAQ:TIG) for €1.78 per share in cash, or €520 million ($617.6 million). The price is an 82% premium to TiGenix’ close of €0.98 in Brussels on Jan. 4, before the deal was announced.

On Friday, TiGenix added €0.72 (73%) to €1.70 in Brussels and $16.86 (71%) to $40.75 on NASDAQ...



Access The Full Article